Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

323 ARTÍCULOS , VIENDO DEL 151 AL 165

[Alzheimer's disease and depression]

Mizukami K.

Seishin Shinkeigaku Zasshi. 2013;115(11):1122-6.

A trial of dementia caregiver telephone support

Martindale-Adams J, Nichols LO, Burns R, Graney MJ, Zuber J.

Can J Nurs Res. 2013 Dec;45(4):30-48. doi: 10.1177/084456211304500404.

Montreal cognitive assessment: validation study for mild cognitive impairment and Alzheimer disease

Freitas S, Simões MR, Alves L, Santana I.

Alzheimer Dis Assoc Disord. 2013 Jan-Mar;27(1):37-43. doi: 10.1097/WAD.0b013e3182420bfe.

Recent advances in imaging Alzheimer's disease

Braskie MN, Toga AW, Thompson PM.

J Alzheimers Dis. 2013;33 Suppl 1(0 1):S313-27. doi: 10.3233/JAD-2012-129016.

Characterizing the preclinical stages of Alzheimer's disease and the prospect of presymptomatic intervention

Caselli RJ, Reiman EM.

J Alzheimers Dis. 2013;33 Suppl 1(0 1):S405-16. doi: 10.3233/JAD-2012-129026.

Lessons from epidemiologic research about risk factors, modifiers, and progression of late onset Alzheimer's Disease in New York City at Columbia University Medical Center

Devanand D, Lee J, Luchsinger J, Manly J, Marder K, Mayeux R, Scarmeas N, Schupf N, Stern Y.

J Alzheimers Dis. 2013;33 Suppl 1(0 1):S447-55. doi: 10.3233/JAD-2012-129041.

An MRI-based index to measure the severity of Alzheimer's disease-like structural pattern in subjects with mild cognitive impairment

Spulber G, Simmons A, Muehlboeck JS, Mecocci P, Vellas B, Tsolaki M, Kłoszewska I, Soininen H, Spenger C, Lovestone S, Wahlund LO, Westman E; dNeuroMed consortium and for the Alzheimer Disease Neuroimaging Initiative.

J Intern Med. 2013 Apr;273(4):396-409. doi: 10.1111/joim.12028. Epub 2013 Jan 30.

Apolipoprotein E and Alzheimer disease: risk, mechanisms and therapy

Liu CC, Liu CC, Kanekiyo T, Xu H, Bu G.

Nat Rev Neurol. 2013 Feb;9(2):106-18. doi: 10.1038/nrneurol.2012.263. Epub 2013 Jan 8.

Cognitive rehabilitation changes memory-related brain activity in people with Alzheimer disease

van Paasschen J, Clare L, Yuen KS, Woods RT, Evans SJ, Parkinson CH, Rugg MD, Linden DE.

Neurorehabil Neural Repair. 2013 Jun;27(5):448-59. doi: 10.1177/1545968312471902. Epub 2013 Jan 31.

Florbetapir (F18-AV-45) PET to assess amyloid burden in Alzheimer's disease dementia, mild cognitive impairment, and normal aging

Johnson KA, Sperling RA, Gidicsin CM, Carmasin JS, Maye JE, Coleman RE, Reiman EM, Sabbagh MN, Sadowsky CH, Fleisher AS, Murali Doraiswamy P, Carpenter AP, Clark CM, Joshi AD, Lu M, Grundman M, Mintun MA, Pontecorvo MJ, Skovronsky DM; AV45-A11 study group.

Alzheimers Dement. 2013 Oct;9(5 Suppl):S72-83. doi: 10.1016/j.jalz.2012.10.007. Epub 2013 Jan 30.

Perturbations of neural circuitry in aging, mild cognitive impairment, and Alzheimer's disease

Leal SL, Yassa MA.

Ageing Res Rev. 2013 Jun;12(3):823-31. doi: 10.1016/j.arr.2013.01.006. Epub 2013 Feb 4.

Cognitive impairment in studies of 5HTTLPR and psychosis in Alzheimer's disease: a systematic review

Creese B, Ballard C, Jones E.

Dement Geriatr Cogn Disord. 2013;35(3-4):155-64. doi: 10.1159/000346733. Epub 2013 Feb 5.

Genetic variation in clusterin gene and Alzheimer's disease risk in Han Chinese

Yu JT, Ma XY, Wang YL, Sun L, Tan L, Hu N, Tan L.

Neurobiol Aging. 2013 Jul;34(7):1921.e17-23. doi: 10.1016/j.neurobiolaging.2013.01.010. Epub 2013 Feb 12.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias